Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective
出版年份 2020 全文链接
标题
Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective
作者
关键词
-
出版物
JOURNAL OF MEDICAL VIROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-08-27
DOI
10.1002/jmv.26462
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study
- (2020) Xi Zhang et al. VACCINE
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
- (2019) Mohamed Zuhair et al. REVIEWS IN MEDICAL VIROLOGY
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
- (2019) Umberto Restelli et al. Infection and Drug Resistance
- Clinical and economic burden of pre‐emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients
- (2019) Lynn El Haddad et al. JOURNAL OF MEDICAL VIROLOGY
- Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
- (2018) Nico Gagelmann et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study
- (2018) Robin K. Avery et al. Transplant Infectious Disease
- The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
- (2018) Brandon J. Webb et al. Transplant Infectious Disease
- Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
- (2018) Farnaz Foolad et al. Expert Review of Clinical Pharmacology
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012
- (2017) Eric Tai et al. Journal of Oncology Practice
- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation
- (2015) Michael Boeckh et al. ANNALS OF INTERNAL MEDICINE
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease
- (2015) Divaya Bhutani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytomegalovirus infection in transplant recipients
- (2015) LS Azevedo et al. Clinics
- Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
- (2014) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches
- (2014) Natasha A. Jain et al. CYTOTHERAPY
- Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study
- (2014) Annemieke Leunis et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation
- (2013) Ren Lin et al. Journal of Hematology & Oncology
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients
- (2012) Andrea Bacigalupo et al. Expert Review of Anti-Infective Therapy
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
- (2010) Nathan Cantoni et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
- (2010) Sheri Lewis Bate et al. CLINICAL INFECTIOUS DISEASES
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started